Gale Smith
Chief Tech/Sci/R&D Officer chez NOVAVAX, INC.
Profil
Le Dr Gale E. Smith est scientifique en chef et vice-président principal chargé de la découverte chez Novavax, Inc. Il a obtenu son diplôme de premier cycle à l'Université du Dakota du Nord et un doctorat à l'Université A&M du Texas.
Postes actifs de Gale Smith
Sociétés | Poste | Début |
---|---|---|
NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Gale Smith
Sociétés | Poste | Fin |
---|---|---|
Protein Sciences Corp.
Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Chief Tech/Sci/R&D Officer | - |
Formation de Gale Smith
Texas A&M University | Doctorate Degree |
University of North Dakota | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NOVAVAX, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Protein Sciences Corp.
Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT. | Health Technology |